B. Braun Recalls Streamline Hemodialysis Bloodline Sets

The medical device manufacturer is removing specific bloodline sets due to a risk of potential detachment or leakage.

Updated on Oct. 27, 2026 in Healthcare

Isometric editorial illustration of a sterile medical dialyzer connector and tubing, representing the clinical manufacturing recall of medical supplies.
Medical device manufacturer B. Braun has issued a recall for its Streamline bloodline sets used in hemodialysis due to a manufacturing defect. AI Illustration. Upload story photo >

Live Poll

Do you trust that medical device companies effectively notify patients and providers when safety issues arise?

B. Braun is recalling its Streamline Bloodline Set used with Dialog+ hemodialysis devices following an assembly error. The defect involves inadequate bonding of the dialyzer connector that may cause the component to fail during treatment.

Why it matters

The recall is a precautionary measure because a detached or leaking connector could compromise the safety and efficacy of dialysis treatments. While the issue poses a risk during priming or patient sessions, no serious injuries or deaths have been reported to date.

The recall affects product model SL-2010M2096 and three specific lots: A2600099, A2600128, and A2600136. Affected UDI-DI device identifiers are 04046964367786 and 04046964367779.

The players

B. Braun

B. Braun is a global medical device and pharmaceutical company that manufactures equipment for healthcare providers.

FDA

The Food and Drug Administration is the federal agency responsible for protecting public health by regulating medical devices in the United States.

The details

The defect stems from a failure to perform a required solvent application step during the manufacturing assembly process. This oversight prevents the dialyzer connector from securely bonding, potentially leading to leaks during clinical use.

Timeline

  1. As of October 10, 2026, no injuries or deaths have been reported.

  2. B. Braun sent notification letters to affected customers on October 20, 2026.

Market Landscape

This recall reflects the ongoing industry focus on quality assurance within the highly regulated clinical hemodialysis sector. It highlights the reliance on strict manufacturing protocols to maintain patient safety across a competitive market of dialysis device providers.

Patients or healthcare providers using Dialog+ devices should verify their equipment model numbers against the recalled lot identifiers provided by the manufacturer. If facilities have these specific sets in inventory, they should follow B. Braun's instructions for removal and customer support.

The takeaway

Medical device recalls rely on clear communication between manufacturers and clinical facilities to prevent equipment failure. Users should always cross-reference their specific unit numbers with official recall documentation to ensure clinical safety.

Further reading

For broader trends in medical equipment safety, visit the Healthcare section.

More information

View the FDA medical device recall alert page for complete details on the affected hardware.

Source note: This article includes information reported by U.S. Food and Drug Administration.

Live Poll

Do you trust that medical device companies effectively notify patients and providers when safety issues arise?